Review Topical Sections

Regulated intramembrane proteolysis, innate immunity and therapeutic targets in Alzheimer’s disease

  • The critical discovery of the presenilins and their association with familial Alzheimer’s disease (AD) prompted an intensive research effort to understand the molecular mechanisms of that disease. The presenilins were subsequently found to be the catalytic component of the multi-protein enzyme complex, γ-secretase, the enzyme that is known to act on the amyloid precursor protein (APP) to generate amyloid beta (Aβ) peptides that comprise the neuritic plaques implicated in AD pathology. Here, we discuss the background of γ-secretase- mediated proteolysis of APP and its association with familial AD. We discuss the association of neuroinflammation with AD, focusing on the link between the innate immune response, the clearance of the Aβ peptides and disease progression. Currently, there are limited treatments for AD that strive to ameliorate the symptoms of the disease but do not address the molecular basis of the disease. The greater understanding of γ- secretase functions has provided new insights into potential therapeutics for AD, a number of which are in clinical trials.

    Citation: Tara P. Hurst, Caroline Coleman-Vaughan, Indu Patwal, Justin V. McCarthy. Regulated intramembrane proteolysis, innate immunity and therapeutic targets in Alzheimer’s disease[J]. AIMS Molecular Science, 2016, 3(2): 138-157. doi: 10.3934/molsci.2016.2.138

    Related Papers:

    [1] Yuxuan Zhang, Xinmiao Rong, Jimin Zhang . A diffusive predator-prey system with prey refuge and predator cannibalism. Mathematical Biosciences and Engineering, 2019, 16(3): 1445-1470. doi: 10.3934/mbe.2019070
    [2] Yun Kang, Sourav Kumar Sasmal, Komi Messan . A two-patch prey-predator model with predator dispersal driven by the predation strength. Mathematical Biosciences and Engineering, 2017, 14(4): 843-880. doi: 10.3934/mbe.2017046
    [3] Yong Luo . Global existence and stability of the classical solution to a density-dependent prey-predator model with indirect prey-taxis. Mathematical Biosciences and Engineering, 2021, 18(5): 6672-6699. doi: 10.3934/mbe.2021331
    [4] Yongli Cai, Malay Banerjee, Yun Kang, Weiming Wang . Spatiotemporal complexity in a predator--prey model with weak Allee effects. Mathematical Biosciences and Engineering, 2014, 11(6): 1247-1274. doi: 10.3934/mbe.2014.11.1247
    [5] Eric M. Takyi, Charles Ohanian, Margaret Cathcart, Nihal Kumar . Dynamical analysis of a predator-prey system with prey vigilance and hunting cooperation in predators. Mathematical Biosciences and Engineering, 2024, 21(2): 2768-2786. doi: 10.3934/mbe.2024123
    [6] Jin Zhong, Yue Xia, Lijuan Chen, Fengde Chen . Dynamical analysis of a predator-prey system with fear-induced dispersal between patches. Mathematical Biosciences and Engineering, 2025, 22(5): 1159-1184. doi: 10.3934/mbe.2025042
    [7] Lazarus Kalvein Beay, Agus Suryanto, Isnani Darti, Trisilowati . Hopf bifurcation and stability analysis of the Rosenzweig-MacArthur predator-prey model with stage-structure in prey. Mathematical Biosciences and Engineering, 2020, 17(4): 4080-4097. doi: 10.3934/mbe.2020226
    [8] Yuanfu Shao . Bifurcations of a delayed predator-prey system with fear, refuge for prey and additional food for predator. Mathematical Biosciences and Engineering, 2023, 20(4): 7429-7452. doi: 10.3934/mbe.2023322
    [9] Swadesh Pal, Malay Banerjee, Vitaly Volpert . Spatio-temporal Bazykin’s model with space-time nonlocality. Mathematical Biosciences and Engineering, 2020, 17(5): 4801-4824. doi: 10.3934/mbe.2020262
    [10] Eric Ruggieri, Sebastian J. Schreiber . The Dynamics of the Schoener-Polis-Holt model of Intra-Guild Predation. Mathematical Biosciences and Engineering, 2005, 2(2): 279-288. doi: 10.3934/mbe.2005.2.279
  • The critical discovery of the presenilins and their association with familial Alzheimer’s disease (AD) prompted an intensive research effort to understand the molecular mechanisms of that disease. The presenilins were subsequently found to be the catalytic component of the multi-protein enzyme complex, γ-secretase, the enzyme that is known to act on the amyloid precursor protein (APP) to generate amyloid beta (Aβ) peptides that comprise the neuritic plaques implicated in AD pathology. Here, we discuss the background of γ-secretase- mediated proteolysis of APP and its association with familial AD. We discuss the association of neuroinflammation with AD, focusing on the link between the innate immune response, the clearance of the Aβ peptides and disease progression. Currently, there are limited treatments for AD that strive to ameliorate the symptoms of the disease but do not address the molecular basis of the disease. The greater understanding of γ- secretase functions has provided new insights into potential therapeutics for AD, a number of which are in clinical trials.


    For decades, many researchers have studied and established mathematical models describing interactions among species. Initially, most studies primarily focused on various types of interaction mechanisms and models using random dispersal of species. The importance of species dispersal, which is one of the main factors involved in species behavior, led to the establishment of more realistic models for species dispersal, for example, self-cross diffusion [1,2,3,4,5,6,7,8,9,10], advection-diffusion [11,12,13,14,15,16,17,18,19,20], and other types of non-uniform dispersal [21,22,23,24,25,26,27,28] models. For the predator–prey interaction, a popular way of describing the dispersal mechanism of predators is using prey-taxis [29,30,31,32,33,34]. There are some predator dispersal types such as the cross diffusion [2,3,4,5,6] and starvation-driven diffusion [22,25]. However, most models describing the dispersal mechanism of predators were dependent on prey's population density.

    In this paper, we examine the predator–prey model describing a situation wherein the predator dispersal depends on other environmental factors rather than prey density. Here, we consider the following model with a directional dispersal of a predator in a spatially heterogeneous environment:

    $ \left\{ ut=μΔu+u(m(x)u)α(x)uvu+d(x)vvt=(ηvχvβ)+v(c+β(x)uu+d(x)v)inΩ×(0,),un=ηvnχvβn=0onΩ×(0,),u(x,0)=u0(x)0,v(x,0)=v0(x)0inΩ,
    \right. $
    (P)

    where $ \Omega $ is a bounded convex domain in $ \mathbb{R}^n $. The zero-flux condition is provided on the smooth boundary $ \partial\Omega $, where $ \vec{n} $ is the outward unit normal vector on the boundary. The functions $ u(x, t) $ and $ v(x, t) $ represent the population densities of the prey and predator, respectively. $ m(x) $ is the growth rate of the prey depending on the location $ x\in\Omega $, and $ \mu $ and $ \eta $ are the diffusion rates of the prey and predator, respectively. $ \alpha(x) $ is a positive function representing the capturing rate. $ \beta(x) $ is proportional to $ \alpha(x) $, $ \beta = k\alpha $, where $ k > 0 $ is a conversion efficiency of food into offspring. A positive function $ d(x) $ is a measure of the interference for the predators during hunting the prey. $ c $ and $ \chi $ are positive constants representing the death rate of the predator and taxis sensitivity coefficient, respectively. The reaction term of the predator represents a case wherein the predator is fed only using the prey. To describe the predator–prey interaction, a ratio-dependent functional response is adopted. By considering the spatially heterogeneous environment, we use the predator-dependent form, such as the ratio-dependent form, for the system [35,36,37].

    The model (P) represents a situation wherein the predator dispersal is unaffected by the prey density. The evolution of prey's behavior and traits has helped them against the threats of the predators. Consequently, these evolved traits and behaviors, for example, nocturnality [38,39], camouflage and masquerade [40,41], or living underground [42], make it difficult for the predators to chase the prey directly. This implies that the prey density does not affect the predator dispersal anymore. In response to defensive mechanisms of the prey, predators not only memorize the location where the prey was detected before but also learn the locations to hunt the prey in their habitat efficiently. Some studies have investigated the searching mechanism depending on such spatial memory [43,44,45,46]. In [43], the artificial experiments using birds was introduced, which provided some evidence of such animal learning to find better locations (see [43] and references therein). Thus, we assume that the prey has evolved to avoid detection from the predator, and the predator disperses using a spatial memory from experiences about the good locations to forage efficiently.

    Such predator dispersal is mathematically described using the taxis term $ -\nabla\cdot(\chi v\nabla \beta) $. An attractant function $ \beta(x) $ includes factors such as an encounter with prey and attack success rates. That is, $ \beta(x) $ indicates which area has high or low hunting efficiency for predators. Thus, the taxis term represents that the predator moves toward locations with high foraging efficiency using the spatial memory about $ \beta $, which is a kind of mnemotaxis [44,45]. The reaction–diffusion system with the taxis term has a property that $ v $ is concentrated around the local maximums of $ \beta $ [15,16]. This implies that the predator gathers near the locations that have a high hunting efficiency. Thus, the predators' directional dispersal toward the location with better hunting efficiency can be described using such type of taxis term.

    For the described dispersal mechanism of the predators, two situations can occur. The first situation wherein $ \beta $ is proportional to the resources of prey $ m $ ($ \beta = \kappa m $ for some constant $ \kappa $). This means that the predators move toward locations where the prey is abundant because the prey is distributed along with the distribution of resources. Mathematical and experimental works have been performed on a similar situation that the predators track the prey's resources instead of the prey density [47,48,49]. The second situation in which the distributions of $ \beta $ and $ m $ are different, i.e., $ \beta $ is not proportional to $ m $. This situation can happen because some places are rich with prey but are easy to hide, making it difficult to hunt for predators, or because the predators memorized correctly, but the environment of prey's habitat has changed due to external factors. This situation seems to be disadvantageous to the predators. Thus, this paper aimed to show the effect of the directional movement of predators in both situations.

    In our model, we let $ w = e^{ -\chi \beta (x)/\eta }v $. Then, an alternative form of (P) is obtained as follows:

    $ \left\{ ut=μΔu+u(m(x)u)α(x)uwu+d(x)weχβ(x)eχβ(x)/ηwt=ηΔw+χβw+w(c+β(x)uu+d(x)weχβ(x)/η)inΩ×(0,),un=wn=0onΩ×(0,),u(x,0)=u0(x)0,w(x,0)=w0(x)0inΩ,
    \right. $
    (P')

    where $ w(x_0) = e^{ -\chi \beta (x)/\eta }v_0 $. Throughout this paper, we give assumptions on $ m $, $ \alpha $ and $ \beta $:

    $ m(x),\alpha (x),\beta (x)\;\;{\rm{and}}\;\;d(x)\;\;{\rm{are}}\;\;{\rm{in}}\;\;{C^2}(\bar \Omega ),\;\;\;\int_\Omega {m(x)dx} \gt 0 $ (A)

    Under the assumption (A), the global existence and uniqueness of the classical solution to (P') follows from the Amann's results [50] for quasilinear parabolic equations. And (P') has one semi-trivial solution $ (\theta, 0) $, where $ \theta $ is a unique positive steady state solution of

    $ {μΔu+u(m(x)u)=0inΩ,un=0onΩ.
    $
    (1.1)

    In this paper, we first investigate the local stability of the semi-trivial solution $ (\theta, 0) $, which is closely related to the survival of the predator. We also consider the elliptic system of (P'). We show that the elliptic system has a positive solution, called the coexistence steady-state, under the conditions for the instability of $ (\theta, 0) $. We also investigate the nonexistence of the positive solution.

    The remaining part of this paper is organized as follows. In Section 2, we state the main theorems and give a biological explanation. The theorems address the stability of $ (\theta, 0) $ and the existence of a coexistence steady-state. Moreover, the effects of taxis sensitivity $ \chi $ are observed. We provide the proofs of stability theorem using the principal eigenvalue analysis in Section 3. The existence of a coexistence steady-state is shown by the fixed-point index theory in Section 4. In Section 5, we present the numerical simulations for some cases. Section 6 summarizes the results obtained and concludes the paper.

    First, we introduce the results for the stability of $ (\theta, 0) $. The instability of $ (\theta, 0) $ and the positivity of the prey density imply that the predator can invade the region. This implies that the predator can survive in the environment, even though this is rare. This allows us to examine whether the taxis is beneficial to the survival of the predator. As in [29], we can show the positivity of the prey density and $ \liminf_{t\rightarrow\infty}u(x, t) > 0 $ if $ \int_\Omega{m(x)dx} > \int_\Omega{\alpha(x)dx} $. Therefore, if we assume $ \int_\Omega{m(x)dx} > \int_\Omega{\alpha(x)dx} $, the invasibility of the predator can be determined by the instability of $ (\theta, 0) $.

    To study the stability of $ (\theta, 0) $, we consider the following linearized eigenvalue problem of (P') at $ (\theta, 0) $:

    $ {μΔϕ+(m(x)2θ)ϕα(x)eχβ(x)/ηψ=λϕinΩ,ηΔψ+χβψ+(c+β(x))ψ=λψinΩ,ϕn=ψn=0onΩ.
    $
    (2.1)

    We multiply $ e^{\chi\beta/\eta} $ by the second equation of Eq (2.1) and obtain

    $ η(eχβ/ηψ)+(c+β(x))eχβ/ηψ=λeχβ/ηψ.
    $
    (2.2)

    Equation (2.2) is the weighted eigenvalue problem $ \lambda e^{\chi\beta/\eta}\psi = L\psi $, where $ L\psi = \eta\nabla\cdot(e^{\chi\beta/\eta}\nabla\psi) + (-c+\beta(x))e^{\chi\beta/\eta}\psi $. Since $ L $ is a self-adjoint, we have the following variational form of the principal eigenvalue:

    $ λ1=supψH1(Ω){0},Ωeχβ/ηψ2=1Ωηeχβ/η|ψ|2+(c+β(x))eχβ/ηψ2.
    $

    We denote the principal eigenvalue of the operator $ L $ by $ \lambda_1(L, \chi) $. It is well-known that $ \lambda_1(L, \chi) $ and the local stability of $ (\theta, 0) $ have the following relation: If $ \lambda_1(L, \chi) > 0 $, then $ (\theta, 0) $ is locally unstable; if $ \lambda_1(L, \chi) < 0 $, then $ (\theta, 0) $ is locally stable (see [51]).

    We define the ecological reproduction number $ \mathcal{R}_0 $ as

    $ R0=supψH1(Ω){0}Ωβ(x)eχβ/ηψ2Ωηeχβ/η|ψ|2+ceχβ/ηψ2>0.
    $
    (2.3)

    Thus, we have the following lemma whose proof is analogous to the proof of Lemma 2, 3 in [52].

    Lemma 2.1. $ \mathcal{R}_0 > 1 $ if and only if $ \lambda_1(L, \chi) > 0 $.

    Lemma 2.1 implies that $ (\theta, 0) $ is unstable if $ \mathcal{R}_0 > 1 $, and $ (\theta, 0) $ is locally asymptotically stable if $ \mathcal{R}_0 < 1 $. Then, $ \mathcal{R}_0 $ has a similar role as the basic reproduction number in epidemiology. This means that the survival of the predator is determined by the sign of $ \mathcal{R}_0-1 $.

    Now, we introduce the results for the local stability of $ (\theta, 0) $ with an assumption on $ \beta $, $ \frac{\partial\beta}{\partial \vec{n}} = 0 $. For a function $ f $, we denote the average of $ f $ in $ \Omega $ by $ \overline{f} $. We first present the stability result about the predator's death rate $ c $ when $ \frac{\partial\beta}{\partial \vec{n}} = 0 $.

    Theorem 2.2. Let $ \eta > 0, \chi\geq0 $ be given. If $ \frac{\partial\beta}{\partial \vec{n}} = 0 $, there exists $ \tilde{c}\in \big(\overline{\beta}-\frac{\chi^2}{4\eta}\overline{|\nabla\beta|^2}, \max_{\bar{\Omega}}\beta \big) $ such that $ (\theta, 0) $ is unstable when $ c < \tilde{c} $, and $ (\theta, 0) $ is locally asymptotically stable when $ c > \tilde{c} $.

    In Theorem 2.2, the sharp criteria for the local stability of $ (\theta, 0) $ about $ c $ is obtained, which represents invasibility of the predator. Given $ \eta > 0 $ and $ \chi\geq0 $, there exists a threshold value $ \tilde{c} $ such that $ \lambda_1(L, \chi) = 0 $ for $ c = \tilde{c} $ and the sign of $ c-\tilde{c} $ determines the stability of $ (\theta, 0) $. From Theorem 2.2, $ (\theta, 0) $ is unstable for all $ \eta > 0 $ when $ c < \overline{\beta} $ and $ \chi = 0 $, but $ \chi > 0 $ gives a possibility $ (\theta, 0) $ to be stable if $ c\in(\overline{\beta}-\frac{\chi^2}{4\eta}\overline{|\nabla\beta|}, \overline{\beta}) $. This means that the directional dispersal could be disadvantageous.

    Next, we give the result for the local stability of $ (\theta, 0) $ about the death rate $ c $ and diffusion rate $ \eta $ of a predator.

    Theorem 2.3. Suppose that $ \frac{\partial\beta}{\partial \vec{n}} = 0 $. Let $ \chi > 0 $ and $ \xi > 0 $ be given constants.

    (i) If $ c > \max_{\bar{\Omega}}\beta $, then $ (\theta, 0) $ is locally asymptotically stable for all $ \eta > 0 $.

    (ii) If $ c < \min_{\bar{\Omega}}\beta $, then $ (\theta, 0) $ is unstable for all $ \eta > 0 $.

    (iii) If $ c < \overline{\beta}-\frac{1}{4\xi}\overline{|\nabla\beta|^2} $, then $ (\theta, 0) $ is unstable when $ \eta > \xi\chi^2 $.

    (iv) Suppose that $ c\in \big(\overline{\beta}-\frac{1}{4\xi}\overline{|\nabla\beta|^2}, \max_{\bar{\Omega}}\beta \big) $. Then $ \tilde{\eta} > 0 $ exists such that if $ \tilde{\eta} < \xi\chi^2 $ then $ (\theta, 0) $ is locally asymptotically stable for $ \eta\in(\tilde{\eta}, \xi\chi^2) $; and if $ \tilde{\eta} > \xi\chi^2 $ then $ (\theta, 0) $ is unstable for $ \eta\in(\xi\chi^2, \tilde{\eta} $).

    Theorem 2.3 gives sufficient conditions of the stability of $ (\theta, 0) $ for the predators' diffusion rate $ \eta $ when $ c $ is in a proper region. A positively given $ \xi $ plays a role for obtaining the sufficient conditions for the stability. For example, we suppose that $ c $ and $ \chi $ such that $ c < \overline{\beta}-\frac{1}{4\xi_1}\overline{|\nabla\beta|^2} $ and $ c\in \big(\overline{\beta}-\frac{1}{4\xi_2}\overline{|\nabla\beta|^2}, \max_{\bar{\Omega}}\beta \big) $ for some $ \xi_1 > \xi_2 $. Then, we obtain from Theorem 2.3 that $ (\theta, 0) $ is unstable for $ \eta > \xi_1\chi^2 $. Moreover, $ (\theta, 0) $ is unstable for $ \eta\in(\xi_2\chi^2, \tilde{\eta}(\xi_2)) $ if $ \tilde{\eta(\xi_2)} > \xi_2\chi^2 $, and $ (\theta, 0) $ is locally asymptotically stable for $ \eta\in(\tilde{\eta}, \xi_2\chi^2) $ if $ \tilde{\eta} < \xi_2\chi^2 $.

    Now, we investigate the effect of taxis $ \chi $ for fixed $ c $ and $ \eta $.

    Theorem 2.4. Suppose that $ \beta $ has at least one isolated global maximum point and $ \max_{\bar{\Omega}}\beta > c $. For given $ \eta > 0 $, there exists $ \tilde{\chi} > 0 $ such that if $ \chi\geq \tilde{\chi} $ then $ (\theta, 0) $ is unstable.

    From Theorem 2.4, we can compare the stability of $ (\theta, 0) $ with or without the predator's directional movement. Without the taxis ($ \chi = 0 $), the predator cannot survive when they are rare for $ (c, \eta)\in (\overline{\beta}, \max_{\bar{\Omega}}\beta)\times (\eta^*, \infty) $ for some $ \eta^* $, which will be immediately shown by lemma in Section 3. However, Theorem 2.4 shows that a large taxis $ \chi > 0 $ makes the predators invade a region. This implies that the strong taxis for predators gives a survival advantage to them compared with a random dispersal.

    Next, we give the final result for the stability of $ (\theta, 0) $ when $ \beta(x) = \kappa m(x) $ for $ x\in\Omega $. Consider the following equation $ A\chi^2 + B\chi + C = 0 $, where

    $ A=κ24ηΩ|m|2θ2dx,B=κΩθθmdx,C=Ωη|θ|2+(κmc)θ2dx.
    $
    (2.4)

    If $ B $ is positive and $ B^2-4AC > 0 $, the equation has two real roots $ \chi_1 < \chi_2 $ such that $ \chi_2 $ is positive.

    Theorem 2.5. Suppose that $ m $ is positive, $ \beta = \kappa m $ for some constant $ \kappa > 0 $ and $ \max_{\bar{\Omega}}\beta > c $. If $ B^2-4AC > 0 $, $ (\theta, 0) $ is unstable when $ \chi\in(\max\{\chi_1, 0\}, \chi_2) $.

    Remark that $ \beta(x) = \kappa m(x) $ implies that the predator moves toward the favorable habitat of the prey. Because the prey has a property to be distributed according to $ m(x) $, such movement of the predator allows them to go to an environment where the prey population is sufficient. Moreover, as the assumption $ \beta(x) = \kappa m(x) $ gives two effects, which are taxis toward the location with an abundance of prey and high hunting efficiency, the fitness of the predator increases. Therefore, a proper taxis sensitivity provides a survival advantage to the predator without the assumption on $ \beta $ in Theorem 2.4 for which predators cannot survive without taxis (Theorem 2.5).

    Consider the steady-state of the system (P'):

    $ {μΔu+u(m(x)u)α(x)uwu+d(x)weχβ(x)/ηeχβ(x)/η=0ηΔw+χβw+w(c+β(x)uu+d(x)weχβ(x)/η)=0inΩ,un=wn=0onΩ.
    $
    (2.5)

    In Eq (2.5), the ratio-dependent functional response is not defined at $ (u, w) = (0, 0) $. Since

    $ \lim\limits_{(u, w)\rightarrow (0, 0)} \frac{uwe^{ \chi \beta (x)/\eta }}{ u + d(x)we^{ \chi \beta (x)/\eta }} = 0, $

    we can extend the domain of $ \frac{ud(x)we^{ \chi \beta (x)/\eta }}{u + d(x)we^{ \chi \beta (x)/\eta }} $ to $ \{(u, w) : u\geq 0, w\geq 0\} $, so that $ (0, 0) $ becomes a trivial solution of Eq (2.5).

    Let a positive solution of Eq (2.5) be a coexistence steady-state. Then, we have the following results for the existence of the coexistence steady-state of Eq (2.5), which is proven using the fixed-point index theory.

    Theorem 2.6. Let $ \eta > 0 $ and $ \chi\geq0 $ be given. If $ \frac{\partial\beta}{\partial \vec{n}} = 0 $, there exists $ \tilde{c}\in \big(\overline{\beta}-\frac{\chi^2}{4\eta}\overline{|\nabla\beta|^2}, \max_{\bar{\Omega}}\beta \big) $ such that Eq (2.5) has at least one coexistence steady state if and only if $ c < \tilde{c} $.

    Theorem 2.7. Suppose that $ \frac{\partial\beta}{\partial \vec{n}} = 0 $. Let $ \chi > 0 $ and $ \xi > 0 $ be given constants.

    (i) If $ c < \overline{\beta}-\frac{1}{4\xi}\overline{|\nabla\beta|^2} $, then Eq (2.5) has at least one coexistence steady state when $ \eta > \xi\chi^2 $.

    (ii) If $ c < \min_{\bar{\Omega}}\beta $, then Eq (2.5) has at least one coexistence steady state for all $ \eta > 0 $.

    (iii) Suppose that $ c\in \big(\overline{\beta}-\frac{1}{4\xi}\overline{|\nabla\beta|^2}, \max_{\bar{\Omega}}\beta \big) $. Then $ \tilde{\eta} > 0 $ exists such that if $ \tilde{\eta} < \xi\chi^2 $ then Eq (2.5) has at least one coexistence steady state for $ \eta\in(\xi\chi^2, \tilde{\eta} $).

    Theorem 2.8. Suppose that $ \beta $ has at least one isolated global maximum point and $ \max_{\bar{\Omega}}\beta > c $. For given $ \eta > 0 $, there exists $ \tilde{\chi} > 0 $ such that if $ \chi\geq \tilde{\chi} $ then Eq (2.5) has at least one coexistence steady state.

    Theorem 2.9. Suppose that $ m $ is positive, $ \beta = \kappa m $ for some constant $ \kappa > 0 $ and $ \max_{\bar{\Omega}}\beta > c $. If $ B^2-4AC > 0 $ for given $ A, B $ and $ C $ as Eq (2.4), then Eq (2.5) has at least one coexistence steady state when $ \chi\in(\max\{\chi_1, 0\}, \chi_2) $.

    It is noteworthy that the conditions for the existence of coexistence steady-state are closely related to the sign of $ \lambda_1(L, \chi) $, which will result in the proof of the above theorems. From the results in subsection 2.1, Eq (2.5) has more chance to have the coexistence steady-state when taxis sensitivity $ \chi $ is properly chosen.

    In this section, we prove Theorem 2.2–2.5. Recall that the principal eigenvalue of (2.2) is defined by

    $ λ1(L,χ)=supψH1(Ω){0},Ωeχβ/ηψ2=1Ωηeχβ/η|ψ|2+(c+β(x))eχβ/ηψ2.
    $
    (3.1)

    We assume that $ \frac{\partial\beta}{\partial\vec{n}} = 0 $ and consider $ \varphi = e^{\chi\beta/2\eta}\psi $. Since $ \psi\in H^1(\Omega) $ and $ \beta\in C^2(\bar{\Omega}) $, $ \varphi $ is also in $ H^1(\Omega) $. In addition, a mapping $ \psi\mapsto e^{\chi\beta/2\eta}\psi $ is bijective. Thus, if we take $ \psi = e^{-\chi\beta/2\eta}\varphi $ and take supremum over $ \varphi\in H^1(\Omega) $, we can rewrite the (3.1) as

    $ λ1(L,χ)=supφH1(Ω){0},||φ||2=1Ωη|φ|2+χφφβ+(χ24η|β|2+β(x)c)φ2.
    $
    (EV1)

    Then, by Green's identity and the assumption of $ \beta $, we have

    $ λ1(L,χ)=supφH1(Ω){0},||φ||2=1Ωη|φ|2+(χ2Δβχ24η|β|2+β(x)c)φ2.
    $
    (EV2)

    It can be easily shown from (EV2) that $ \lambda_1(L, \chi) $ is the principal eigenvalue of

    $ {ηΔφ+(χ2Δβχ24η|β|2+β(x)c)=λφinΩ,φn=0onΩ.
    $

    Let $ \psi_1 $ be the principal eigenfunction with respect to $ \lambda_1(L, \chi) $. From (EV2), we obtain

    $ \lambda_1(L, \chi) = \int_\Omega{-\eta|\nabla\varphi_1|^2 + \Big(-\frac{\chi}{2} \Delta \beta -\frac{\chi^2}{4\eta}|\nabla\beta|^2 +\big(\beta(x)-c\big)\Big)\varphi_1^2} , $

    where $ \varphi_1 = e^{\chi\beta/2\eta}\psi_1 $. Since the principal eigenfunction is unique, $ \varphi_1 $ is the principal eigenfunction with respect to $ \lambda_1\Big(\eta\Delta -\frac{\chi}{2} \Delta \beta -\frac{\chi^2}{4\eta}|\nabla\beta|^2 +\big(\beta(x)-c\big)\Big) $. Therefore, $ \lambda_1(L, \chi) = \lambda_1\Big(\eta\Delta -\frac{\chi}{2} \Delta \beta -\frac{\chi^2}{4\eta}|\nabla\beta|^2 +\big(\beta(x)-c\big)\Big) $. We will utilize the forms (EV1) and (EV2) in proving our results.

    Before proving the theorems, we introduce some properties of the principal eigenvalue. The first property is well-known; the proof is omitted here (See [53]).

    Lemma 3.1. Let $ \lambda_1(\eta\Delta+g(x)) $ be the principal eigenvalue of

    $ {ηΔψ+g(x)ψ=λψinΩ,ψn=0onΩ.
    $
    (3.2)

    Then,

    (i) $ \lambda_1(\eta\Delta+g(x)) $ is monotone decreasing function to $ \eta $;

    (ii) $ \lambda_1(\eta\Delta+\tilde{g}(x))\geq\lambda_1(\eta\Delta+g(x)) $ for a function $ \tilde{g}(x)\geq g(x) $;

    (iii) $ \lim_{\eta\rightarrow0}\lambda_1(\eta\Delta+g(x)) = \max_{x\in\bar{\Omega}}g(x) $;

    (iv) $ \lim_{\eta\rightarrow\infty}\lambda_1(\eta\Delta+g(x)) = \overline{g}. $

    Lemma 3.2. Let $ \lambda_1(\eta\Delta+g(x)) $ be the principal eigenvalue of (3.2).

    (i) If $ g(x) < 0 $, then $ \lambda_1(\eta\Delta+g(x)) < 0 $.

    (ii) If $ \overline{g} > 0 $, then $ \lambda_1(\eta\Delta+g(x)) > 0 $.

    (iii) If $ \int_\Omega{g(x)dx} < 0 $ and $ g(x) $ is positive somewhere, then there exists $ \tilde{\eta} > 0 $ such that $ \lambda_1(\eta\Delta+g(x))\geq0 $ if and only if $ \eta\leq\tilde{\eta} $. The equality holds when $ \eta = \tilde{\eta} $.

    Proof. (i) is obvious by the definition of the principal eigenvalue.

    (ii) Suppose $ \int_\Omega{g(x)dx} > 0 $. From the definition of $ \lambda_1(\eta\Delta + g(x)) $,

    $ λ1(ηΔ+g(x))=supψH1(Ω){0},||ψ||2=1Ωη|ψ|2+g(x)ψ2dx¯g>0.
    $

    (iii) Let $ S: = \{x:g(x) > 0\}\neq \emptyset $. Then, we can choose a test function $ \tilde{\psi} $ with $ ||\tilde{\psi}||_2 = 1 $ whose support is in $ S $. Then, we obtain

    $ λ1Ωη|˜ψ|2+g(x)˜ψ2dx=Sη|˜ψ|2+g(x)˜ψ2dx>0
    $

    for sufficiently small $ \eta $. Since $ \lambda_1(\eta\Delta+g(x)) $ is monotone decreasing function to $ \eta $ and $ \lim_{\eta\rightarrow\infty}\lambda_1(\eta\Delta+g(x)) = \overline{g} < 0 $, there exists $ \tilde{\eta} $ such that if $ \eta > \tilde{\eta} $, then $ \lambda_1(\eta\Delta+g(x)) < 0 $, and if $ \eta < \tilde{\eta} $, then $ \lambda_1(\eta\Delta+g(x)) > 0 $, which is a desired result.

    Now, we first give the proof Theorems 2.2 and 2.3.

    Proof of Theorem 2.2. From the definition of the principal eigenvalue (3.1), we have

    $ \lambda_1(L, \chi) = \sup\limits_{\psi\in H^1(\Omega) \setminus\{0\}, \int_\Omega{e^{\chi\beta/\eta}\psi^2} = 1}\int_\Omega{-\eta e^{\chi\beta/\eta} |\nabla\psi|^2 + (-c+\beta(x))e^{\chi\beta/\eta}\psi^2} \lt 0 $

    for $ c > \max_{\bar{\Omega}}\beta $.

    Next, from (EV2) and $ \frac{\partial\beta}{\partial\vec{n}} = 0 $, we obtain

    $ λ1(L,χ)=λ1(ηΔχ2Δβχ24η|β|2+(β(x)c))=Ωη|φ1|2+(χ2Δβχ24η|β|2+(β(x)c))φ21,
    $

    where $ \varphi_1 $ is the principal eigenfunction with respect to $ \lambda_1\Big(\eta\Delta -\frac{\chi}{2} \Delta \beta -\frac{\chi^2}{4\eta}|\nabla\beta|^2 +\big(\beta(x)-c\big)\Big) $. Also, by the Green's first identity, we have

    $ ΩΔβ(x)dx=ΩβndS=0.
    $
    (3.3)

    It follows from Eq (3.3) and Lemma 3.2 that

    $ λ1(ηΔχ2Δβχ24η|β|2+(β(x)c))>0forc<¯βχ24η¯|β|2.
    $

    Also, since Eq (3.1) and (EV2) are equivalent form of the principal eigenvalue,

    $ \lambda_1\Big(\eta\Delta -\frac{\chi}{2} \Delta \beta -\frac{\chi^2}{4\eta}|\nabla\beta|^2 +\big(\beta(x)-c\big)\Big) \lt 0\quad\mbox{for}\;\; c \gt \max\limits_{\bar{\Omega}}\beta. $

    By Lemma 3.1 (ii), $ \lambda_1\Big(\eta\Delta -\frac{\chi}{2} \Delta \beta -\frac{\chi^2}{4\eta}|\nabla\beta|^2 +\big(\beta(x)-c\big)\Big) $ is monotone decreasing function to $ c $. Then, we can find $ \tilde{c}\in \big(\overline{\beta} -\frac{\chi^2}{4\eta}\overline{|\nabla\beta|^2}, \max_{\bar{\Omega}}\beta \big) $ such that $ \lambda_1\Big(\eta\Delta -\frac{\chi}{2} \Delta \beta -\frac{\chi^2}{4\eta}|\nabla\beta|^2 +\big(\beta(x)-c\big)\Big) = 0 $. By the monotonicity of $ \lambda_1(L, \chi) $ to $ c $, $ (\theta, 0) $ is unstable when $ c < \tilde{c} $, and $ (\theta, 0) $ is locally asymptotically stable when $ c > \tilde{c} $.

    Proof of Theorem 2.3. As in the proof of Theorem 2.2, it suffices to check the sign of $ \lambda_1(L, \chi) $. From the form Eq (3.1), (i) and (ii) are immediately obtained.

    For (iii), we denote $ \lambda_1\Big(\eta\Delta -\frac{\chi}{2} \Delta \beta -\frac{\chi^2}{4\eta}|\nabla\beta|^2 +\big(\beta(x)-c\big)\Big) $ by $ \tilde{\lambda} $. Consider an eigenvalue problem as follows:

    $ {ηΔφ+(χ2Δβ14ξ|β|2+(β(x)c))φ=λφinΩ,φn=0onΩ.
    $
    (3.4)

    Then, the principal eigenvalue of Eq (3.4) can be written by

    $ λ1(ηΔχ2Δβ14ξ|β|2+(β(x)c))=supφH1(Ω){0},||φ||2=1Ωη|φ|2+(χ2Δβ14ξ|β|2+(β(x)c))φ2,
    $

    From Lemma 3.1 (ii),

    $ ˜λ>λ1(ηΔχ2Δβ14ξ|β|2+(β(x)c))if and only if η>ξχ2.
    $
    (3.5)

    Then, the results (iii) follows from Lemma 3.2.

    (iv) Assume that $ c\in \big(\overline{\beta}-\frac{1}{4\xi}\overline{|\nabla\beta|^2}, \max_{\bar{\Omega}}\beta \big) $. By Lemma 3.2 (iii), there exists $ \tilde{\eta} > 0 $ depending on $ \xi $ and $ \chi $ such that $ \lambda_1\Big(\eta\Delta -\frac{\chi}{2} \Delta \beta -\frac{1}{4\xi}|\nabla\beta|^2 +\big(\beta(x)-c\big)\Big) < 0 $ if and only if $ \eta > \tilde{\eta} $. For $ \tilde{\eta} < \xi\chi^2 $, $ (\tilde{\eta}, \xi\chi^2) $ is a non-empty interval. Then, it follows form (3.5) that $ \tilde{\lambda} < 0 $ when $ \eta\in(\tilde{\eta}, \xi\chi^2) $, and thus $ (\theta, 0) $ is locally asymptotically stable. Similarly, for $ \tilde{\eta} > \xi\chi^2 $, $ (\theta, 0) $ is unstable when $ \eta\in(\xi\chi^2, \tilde{\eta}) $.

    Next, we prove Theorem 2.4.

    Proof of Theorem 2.4. It can be proved similarly to Theorem 4.4 in [15]. For reader's convenience, we give the proof here. Since the principal eigenvalue of (2.2) is

    $ \lambda_1(L, \chi) = \sup\limits_{\psi\in H^1(\Omega) \setminus\{0\}, \int_\Omega{e^{\chi\beta/\eta}\psi^2} = 1}\int_\Omega{-\eta e^{\chi\beta/\eta} |\nabla\psi|^2 + (-c+\beta(x))e^{\chi\beta/\eta}\psi^2}, $

    we only need to find a function $ \Psi $ with $ \int_\Omega{e^{\chi\beta/\eta}\Psi^2} = 1 $ such that

    $ Ωηeχβ/η|Ψ|2<Ω(c+β(x))eχβ/ηΨ2.
    $
    (3.6)

    From the assumption, a point $ x_0\in\bar{\Omega} $ exists satisfying $ \beta(x_0) = \max_{\bar{\Omega}}\beta $ and $ \beta(x_0)-c\geq \delta $ for some $ \delta > 0 $. Let $ R_1 > 0 $ be small such that $ \beta(x)-c\geq \frac{1}{2}\delta $ in $ B_{R_1}(x_0)\cap\Omega $, where $ B_{R_1}(x_0) $ is a ball of radius $ R_1 $ and centered at $ x_0 $. We define $ \beta_1 = \max_{(B_{R_1}(x_0)\setminus B_{R_1/2}(x_0))\cap\Omega}\beta $ and $ \beta_2 = \min_{B_{R_2}(x_0)\cap\Omega}\beta $ for $ R_1, R_2 > 0 $. Since the global maximum point is isolated,

    $ \beta_2\geq \frac{1}{2}[\beta_1+\beta(x_0)] \gt \beta_1 $

    for sufficiently small $ R_2 $ satisfying $ R_2\leq R_1/2 $.

    Define a function $ \Phi\in C^1(\bar{\Omega}) $ as

    $ Φ={1in BR1/2(x0)Ω,[0,1]in (BR1(x0)BR2(x0))Ω,0otherwise.
    $

    If we put $ \Psi: = \Phi/\big(\int_\Omega{e^{\chi\beta/\eta}\Phi^2}\big)^{1/2} $ in Eq (3.6), the left-hand side becomes

    $ Ωηeχβ/η|Ψ|2=η(BR1(x0)BR2(x0))Ωeχβ/η|Ψ|2C1(BR1(x0)BR2(x0))Ωeχβ/ηC1|Ω|e(χ/η)β1,
    $

    where $ C_1 $ satisfies $ ||\nabla\Psi||_\infty\leq C_1 $. The right-hand side of Eq (3.6) is

    $ Ω(c+β(x))eχβ/ηΨ2=BR1(x0)Ω(c+β(x))eχβ/ηΨ2e(χ/η)β2BR2(x0)Ω(c+β(x))C2e(χ/η)β2
    $

    for some positive constant $ C_2 $. Since $ C_1 $ and $ C_2 $ is independent of $ \chi $, Eq (3.6) holds if we choose $ \chi $ large enough. Hence, we have a desired result.

    Finally, we assume that $ \beta(x) = \kappa m(x) $ for $ x\in\Omega $, which is the assumption in Theorem 2.5. Before proving the theorem, we give a known result in [14].

    Lemma 3.3 (Cantrell et al. [14]). The integral $ \int_\Omega{\theta \nabla\theta\cdot\nabla m dx} $ is positive if $ \Omega\subseteq\mathbb{R} $ is an interval or if $ \Omega\subseteq \mathbb{R}^n $ is convex.

    Then, we give the proof of Theorem 2.5.

    Proof of Theorem 2.5. Let $ \lambda_1(L, \chi) $ be the principal eigenvalue with the form (EV1). Since $ \beta(x) = \kappa m(x) $ for $ x\in\Omega $,

    $ λ1(L,χ)=supφH1(Ω){0},||φ||2=1Ωη|φ|2+κχφφm+(κ2χ24η|m|2+κmc)φ2Ωη|θ|2+κχθθm+(κ2χ24η|m|2+κmc)θ2/Ωθ2dx=(Aχ2+Bχ+C)/Ωθ2dx,
    $

    where $ A, B $ and $ C $ are given as Equation (2.4). Since $ B^2-4AC > 0 $, $ A < 0 $ and $ B > 0 $ by Lemma 3.3, the equation has two real roots $ \chi_1 $ and $ \chi_2 $ with at least one positive solution, say $ \chi_2 $. Then, $ A\chi^2 +B\chi +C > 0 $ for $ \chi_1 < \chi < \chi_2 $. which implies $ (\theta, 0) $ is unstable for $ \chi\in(\max\{\chi_1, 0\}, \chi_2) $. We note that $ B^2-4AC $ cannot be positive for $ c > \max_{\bar{\Omega}}\beta $, because $ (\theta, 0) $ is locally asymptotically stable ($ \lambda_1 < 0 $) when $ c > \max_{\bar{\Omega}}\beta $. Hence, Theorem 2.5 is valid for $ c < \max_{\bar{\Omega}}\beta $.

    In this section, we present the proofs of Theorems 2.6–2.8 which are about the existence and non-existence of the coexistence steady-states of Eq (2.5). Before proving the theorems, we introduce the fixed-point index theory.

    Fixed-point index theory

    Let $ E $ be a real Banach space and $ W \subset E $ a closed convex set. $ W $ is called a total wedge if $ \alpha W \subset W $ for all $ \alpha \geq 0 $ and $ \overline{W\cup (-W)} = E $. A wedge is said to be a cone if $ W \cap (-W) = \{0\} $. For $ y \in W $, we define $ W_y = \{ x \in E\; :\; y + \gamma x \in W \; \; \mbox{for some}\; \; \gamma > 0 \} $ and $ S_y = \{ x \in {\overline W}_y \; :\; -x \in {\overline W}_y\} $. Then, $ {\overline W}_y $ is a wedge containing $ W $, $ y $ and $ -y $, while $ S_y $ is a closed subspace of $ E $ containing $ y $.

    Let $ T $ be a compact linear operator on $ E $ satisfying $ T({\overline W}_y) \subset {\overline W}_y $. We say that $ T $ has property $ \alpha $ on $ {\overline W}_y $ if there are $ t \in (0, 1) $ and $ w \in {\overline W}_y \backslash S_y $ such that $ w - tTw \in S_y $. Let $ F : W \rightarrow W $ is a compact operator with a fixed-point $ y \in W $ and $ F $ is Fréchet differentiable at $ y $. Let $ L = F'(y) $ be the Fréchet derivative of $ F $ at $ y $. Then, $ L $ maps $ {\overline W}_y $ into itself. For an open subset $ U \subset W $, define $ \operatorname{index}_W(F, U) = \operatorname{index}(F, U, W) = \operatorname{deg}_W (I-F, U, 0) $, where $ I $ is the identity map. If $ y $ is an isolated fixed-point of $ F $, then the fixed-point index of $ F $ at $ y $ in $ W $ is defined by $ \operatorname{index}_W(F, y) = \operatorname{index}(F, y, W) = \operatorname{index}(F, U(y), W) $, where $ U(y) $ is a small open neighborhood of $ y $ in $ W $.

    The following theorem can be obtained from the results of [54,55,56].

    Theorem 4.1. Assume that $ I - L $ is invertible on $ {\overline W}_y $.

    (i) If $ L $ has property $ \alpha $ on $ { \overline W}_y $, then $ \operatorname{index}_W(F, y) = 0 $.

    (ii) If $ L $ does not have property $ \alpha $ on $ { \overline W}_y $, then $ \operatorname{index}_W(F, y) = (-1)^{\sigma} $, where $ \sigma $ is the sum of multiplicities of all the eigenvalues of $ L $ which are greater than 1.

    Lemma 4.2. Any coexistence state $ (u, w) $ of system (2.5) has an a priori estimate

    $ u(x) \leq Q_{1}, \; w(x) \leq Q_{2}. $

    where $ Q_{1} = \max_{\bar{\Omega}} m, \; Q_{2} = \dfrac{Q_1\max_{\bar{\Omega}}\beta}{c\min_{\bar{\Omega}}d} $.

    Proof. Let $ (u, w) $ be a positive solution of (2.5). Since $ -\mu \Delta u \leq u\Big(m(x) - u \Big) $, we obtain $ u \leq \max_{\bar{\Omega}}{m} $ by maximum principle for elliptic.

    Let $ w(x_0) = \max_{\bar{\Omega}} w $ and $ h = \chi / \eta $. Then, by maximum principle for elliptic equation,

    $ 0 \leq \dfrac{ \beta(x_0) u(x_0)}{u(x_0) + d(x_0) e^{h\beta (x_0)} w(x_0)} - c \leq \dfrac{ \max\limits_{\bar{\Omega}} \beta Q_1}{Q_1 + \min\limits_{\bar{\Omega}}d w(x_0)} - c. $

    Since

    $ c \min\limits_{\bar{\Omega}}d w(x_0) \leq cQ_1 + c\min\limits_{\bar{\Omega}}d w(x_0) \leq \max\limits_{\bar{\Omega}}\beta Q_1, $

    it implies that

    $ \max\limits_{\bar{\Omega}}w \leq \frac{\max\limits_{\bar{\Omega}}\beta }{c\min\limits_{\bar{\Omega}}d} Q_1. $

    Notation 4.3.

    (i) $ X : = C^{1}_{N} (\bar{\Omega}) \bigoplus C^{1}_{N} (\bar{\Omega}) $ where $ C^{1}_{N} (\bar{\Omega}): = \{ \phi \in C^{1}(\bar{\Omega}) : \frac{\partial\phi}{\partial \vec{n}} = 0 \; \; on\; \; \partial \Omega \} $.

    (ii) $ Q : = \max\{ Q_1, Q_2 \} + 1 $.

    (iii) $ D : = D_Q \bigoplus D_Q $ where $ D_Q = \{ \phi \in C^{1}_{N}(\bar{\Omega}) : \phi < Q \; \; on\; \; \bar{\Omega} \} $.

    (iv) $ W : = D_0 \bigoplus D_0 $ where $ D_0 = \{ \phi \in C^{1}_{N}(\bar{\Omega}) : 0 \leq \phi \; \; on\; \; \bar{\Omega} \} $.

    (v) $ D^{\prime} : = D \cap W $.

    For $ \tau \in [0, 1] $, define a positive compact operator $ F_{\tau} : X \to X $ by $ F_{\tau}(u, w) = (-D\Delta + P)^{-1}[P\mathcal{I} + \tau G](u, w)^{T} $ where

    $G(u, w)^{T} = \left(muu2αueχβ/ηwu+d(x)eχβ/ηwχβw+βueχβ/ηwu+d(x)eχβ/ηwcw
    \right), \qquad D = (μ00η)
    . $

    and $ P $ is a positive constant such that $ (2Q + \frac{\max_{\Omega}\alpha}{\min_{\Omega}d} + \frac{\max_{\Omega} \beta}{{\min_{\Omega}d}} + c)Q + \chi \Vert \nabla \beta \Vert_{\infty}\Vert \nabla w \Vert_{\infty} < P $. $ F_{\tau} $ is positive and compact operator. We denote $ F = F_1 $. Then, (P') has a positive solution if and only if $ F $ has a positive fixed-point.

    For the operator $ F $, we first find the result for the index values, $ \operatorname{index}_{W}(F, D^{\prime}) $ and $ \operatorname{index}_{W}(F, (0, 0)) $. The following lemmas can be proved by similar argument to [57]; the proofs are omitted here.

    Lemma 4.4. $ \operatorname{index}_{W}(F, D^{\prime}) = 1 $.

    Lemma 4.5. $ \operatorname{index}_{W}(F, (0, 0)) = 0 $.

    Next, we calculate the $ \operatorname{index}_{W}(F, (\theta, 0)) $. Remark that the principal eigenvalue $ \lambda_1(L, \chi) $ of Eq (2.2) is real, and the corresponding principal eigenfunction $ \Psi $ is positive. Since the principal eigenpair $ (\lambda_1(L, \chi), \Psi) $ satisfies Eq (2.2), $ (\lambda_1(L, \chi), \Psi) $ also satisfies the second equation of Eq (2.1):

    $ λ1(L,χ)Ψ=ηΔΨ+χβΨ+(c+β(x))ΨinΩ.
    $
    (4.1)

    Lemma 4.6. If $ \lambda_{1}(L, \chi) > 0 $, then $ \operatorname{index}_{W}(F, (\theta, 0)) = 0 $.

    Proof. By calculation, we have

    $ \overline{W}_{(\theta, 0)} = C^{1}_{N}( \overline{\Omega}) \bigoplus D_0 , \;\;S_{(\theta, 0)} = C^{1}_{N}( \overline{\Omega}) \bigoplus \{0 \}. $

    Define

    $ L:=F(θ,0)=(DΔ+P)1(m2θ+Pα0χβ+βc+P).
    $

    We first claim that $ \mathcal{I}-\mathcal{L} $ is invertible. Let $ \mathcal{L}(\phi, \psi)^{T} = (\phi, \psi)^{T} \in \overline{W}_{(\theta, 0)} $.

    $ {μΔϕ=(m2θ)ϕαψηΔψ=χβψ+(βc)ψinΩ,ϕn=ψn=0onΩ.
    $
    (4.2)

    For $ \psi \geq 0 $, multiply the second equation of Eq (4.2) by $ e^{\chi\beta / \eta}\Psi $ and integrate over $ \Omega $, where $ \Psi $ is a principal eigenfunction of $ \lambda_{1}(L, \chi) $. Then, we obtain

    $ 0=Ωeχβ/ηΨ[ηΔψ+χβψ]+eχβ/η(βc)Ψψ=ΩΨ[ηeχβ/ηψ]+eχβ/η(βc)Ψψ=Ωψ[ηeχβ/ηΨ]+eχβ/η(βc)Ψψ=Ωeχβ/ηψ[ηΔΨ+χβΨ+(βc)Ψ]=λ1(L,χ)Ωeχβ/ηΨψ0,
    $

    which implies $ \psi\equiv0 $. The last equality holds from Eq (4.1).

    Since $ \lambda_1(\mu\Delta + (m-\theta)) = 0 $ with the corresponding principal eigenfunction $ \theta $, $ \lambda_1(\mu\Delta + (m-2\theta)) < 0 $ by Lemma 3.1 (ii). We multiply the first equation of Eq (4.2) by $ \phi $ and integrate over $ \Omega $. Then, we have

    $ 0 = \int_{\Omega} \alpha \phi \psi = \int_{\Omega}-\mu |\nabla \phi|^2 + (m - 2\theta) \phi^2 \leq \lambda_1(\mu\Delta + (m-2\theta))\int_{\Omega} {\phi^2} \leq 0. $

    Hence, $ \phi \equiv 0 $ and $ \mathcal{I}-\mathcal{L} $ is invertible.

    Next, we show that $ \mathcal{L} $ has a property $ \alpha $. Let $ r $ be $ \mbox{the spectral radius of} \; (-\eta \Delta + P)^{-1}(\chi \nabla \beta \cdot \nabla + \beta - c + P) $. Then, the assumption $ \lambda_{1}(L, \chi) > 0 $ implies that $ r > 1 $. Then, there exist corresponding eigenfunction $ \xi $ exists in $ D_0\setminus\{0\} $. Take $ t = 1 /r \in (0, 1) $, then

    $ \left(ϕψ
    \right) - t \mathcal{L} \left(ϕψ
    \right) = \left(00
    \right) \in S_{(\theta, 0)} \;\;{\rm{holds }}\;\;{\rm{for}} \quad \left(ϕψ
    \right) = \left(0ξ
    \right) \in \overline{W}_{(\theta, 0)}\setminus S_{(\theta, 0)}.$

    Hence, $ \mathcal{L} $ has property $ \alpha $. By Theorem 4.1 (i), we have $ \operatorname{index}_{W}(F, (\theta, 0)) = 0 $.

    Now, we give the proofs of Theorems 2.6–2.9. Theorems 2.7–2.9 can be proved in a similarly manner; we only give the proof of Theorem 2.6.

    Proof of Theorem 2.6. Suppose that $ \frac{\partial\beta}{\partial \vec{n}} = 0 $. From Theorem 2.2, there exists $ \tilde{c}\in \big(\overline{\beta}-\frac{\chi^2}{4\eta}\overline{|\nabla\beta|^2}, \max_{\bar{\Omega}}\beta \big) $. Then, it follows from Lemma 4.4–4.6 that

    $ 1 = \operatorname{index}_{W}(F, D') \neq \operatorname{index}_{W}(F, (0, 0)) + \operatorname{index}_{W}(F, (\theta, 0)) = 0. $

    Hence, Eq (2.5) has at least one coexistence state for $ c < \tilde{c} $.

    Next, we assume that $ c\geq \tilde{c} $. Suppose that $ (u, w) $ be the positive solution of Eq (2.5). Then, $ (u, w) $ satisfies

    $ ηΔw+χβw+w(c+β(x)uu+d(x)weχβ(x)/η)=0.
    $
    (4.3)

    Let $ \tilde{w}: = w\big/\big(\int_\Omega{e^{\chi\beta/\eta}w^2}\big)^{1/2} $. If we multiply Eq (4.3) by $ e^{\chi\beta/\eta}\tilde{w}/\big(\int_\Omega{e^{\chi\beta/\eta}w^2}\big)^{1/2} $ and integrate over $ \Omega $, we have

    $ 0=Ωηeχβ/η|˜w|2+(β(x)uu+d(x)weχβ/ηc)eχβ/η˜w2=Ωηeχβ/η|˜w|2+(β(x)c)eχβ/η˜w2+(β(x)uu+d(x)weχβ/ηβ(x))eχβ/η˜w2λ1(L,χ)+Ω(β(x)uu+d(x)weχβ/ηβ(x))eχβ/η˜w2.
    $
    (4.4)

    The last inequality holds by the definition of the principal eigenvalue $ \lambda_1(L, \chi) $. From Eq (4.4), we obtain

    $ \lambda_1(L, \chi)\geq \int_\Omega{\Big(\beta(x)-\frac{\beta(x)u}{u+d(x)we^{\chi\beta/\eta}}\Big) e^{\chi\beta/\eta}\tilde{w}^2} \gt 0, $

    which is a contradiction because $ \lambda_1(L, \chi)\leq0 $ under the assumption $ c\geq\tilde{c} $. Hence, there is no positive solution of Eq (2.5) if $ c\geq \tilde{c} $.

    In this section, we present some numerical simulations to verify the mathematical results of this paper. Throughout the simulations, the following parameters and functions are used:

    $ β(x)=0.8α(x),d(x)=0.5+0.1sin(2πx),μ=0.01,u0(x)=0.5+0.2sin(2πx),v0(x)=0.2+0.1sin(2πx),Ω=[0,1].
    $

    We used the upwind scheme with the finite difference method, and the toleration of iteration is selected as $ 10^{-6}. $ The simulation results presented show the important role of directional dispersal with taxis compared to the random dispersal when $ c, \beta $ and $ \eta $ are given.

    Figure 1 shows that a large $ \chi $ gives the predator with directional dispersal a survival advantage when $ c\in\big(\overline{\beta}, \max_{\bar{\Omega}}\beta\big) $. Theorem 2.4 implies that the $ (\theta, 0) $ is locally asymptotically stable when $ \chi = 0 $ for any given $ c $ and $ \eta $, but a large $ \chi $ allows $ (\theta, 0) $ to be unstable. This means that the strong taxis of predator can make them survive under the condition in which the predator with random dispersal cannot survive. Figure 1 shows that such dispersal makes the predator and prey coexist in the environment. It is noteworthy that, as can be seen in Figure 1, the density of the predator is concentrated on the local maximum of $ \beta $, which is a feature of the species with directional dispersal.

    Figure 1.  Stability of semi-trivial solution $ (\theta, 0) $ when $ \overline{\beta} < c < \max_{\bar{\Omega}}\beta $. (a) $ (\theta, 0) $ is locally asymptotically stable when $ \chi = 0 $. (b) $ (\theta, 0) $ is unstable when $ \chi = 0.3 $ $ (\beta = 0.48-0.32\cos(4\pi x), m(x) = 0.6 + 0.4\sin(3\pi x), c = 0.7, \eta = 0.01) $.

    In Figure 2, the case that $ \beta(x) = \kappa m(x) $ is considered. If $ \beta(x) $ has at least one isolated global maximum point, we have a same result in Theorem 2.4 and Figure 1. Thus, we give $ \beta(x) $ as a combination of smoothstep function for Figure 2, which is the case when $ \beta $ has no isolated global maximum point on $ \overline{\Omega} $. Figure 2 shows that the properly chosen taxis sensitivity $ \chi > 0 $ can make the predator survive under the condition when the predator without taxis cannot survive. This represents the result of Theorem 2.5 that the directional dispersal is beneficial for the predator's survival when $ \chi $ is in a proper region regardless of the assumption on $ \beta $. This is a natural ecological result because the taxis of the predators not only makes them move towards the region with high hunting efficiency, but also the prey's favorable habitats where the density of the prey is large.

    Figure 2.  Stability of semi-trivial solution $ (\theta, 0) $ when $ \beta(x) = \kappa m(x) $. (a) $ (\theta, 0) $ is locally asymptotically stable when $ \chi = 0 $. (b) $ (\theta, 0) $ is unstable when $ \chi = 0.01 $. $ (\beta(x) = 0.72m(x), c = 0.73, \eta = 0.01) $.

    In this paper, we suggested the predator–prey model describing the phenomena that the predator moves with taxis toward the region with a high hunting efficiency. For the predator–prey model, most of the studies dealing with taxis have considered the prey-taxis [29,30,31,32,33,34]. Authors in [29] adopted the ratio-dependent functional responses with a spatially heterogeneous environment, which are the same as our model, and they showed that the prey taxis is always beneficial for the predator's survival. However, the predators cannot chase the prey directly because the model we established describes the situation that prey has evolved to avoid detection from the predator. Thus, we considered other type of predators' dispersal mechanism with taxis toward the location where the hunting efficiency is high using the spatial memory [43,44,45,46]. There are two cases of the rate at which predators capture the prey: proportional ($ \beta = \kappa m $) or not proportional ($ \beta\neq \kappa m $) to the resources of prey. For the first case, a similar idea is introduced in [47,48,49] that the predators move in the direction of high prey's resources instead of tracking the prey directly, and [47] established the mathematical model of such dispersal and obtained some mathematical results. The other case can be followed from the prey's defensive mechanisms or environmental change from other external factors. This could make the predators go to a region with low prey density, which seems not helpful for the predators. In this paper, we investigated whether the defensive mechanism of the predators is advantageous to them for both cases.

    Through this article, we determined the criteria and sufficient conditions for the local stability of the semi-trivial solution, which is closely related to the survival of the predators. Furthermore, the conditions for the existence of coexistence steady-state were obtained. We studied the stability and coexistence conditions for the three parameters: the death rate, diffusion, and taxis sensitivity. Finally, the obtained results were verified by using numerical simulations. From a biological perspective, the results for stability indicate that, when the predators have the spatial memory where the location is good to forage efficiently, the taxis toward the location could give a greater chance of invasion than when they disperse randomly (Theorems 2.2, 2.4 and 2.5). This implies that the directional movement toward the region with high foraging efficiency increases the fitness of predators. Consequently, such dispersal helps the predators to invade a region. If $ \beta $ has at least one isolated global maximum point, the dispersal is advantageous to the predator's survival when taxis is strong even though $ \beta $ is not proportional to $ m $ (Theorem 2.4). This represents that the dispersal mechanism also affects to the predators fitness regardless the distributions of $ \beta $ and $ m $. When $ \beta $ has no isolated global maximum, the proper taxis sensitivity gives survival advantage to the predators (Theorem 2.5). This means that the properly chosen taxis sensitivity helps predators survive regardless of assumption on $ \beta $ when the predators have directional movement toward the location with abundant prey and high hunting efficiency ($ \beta $ is proportional to $ m $). Moreover, as a dictum in ecology that "invasibility implies coexistence, " the taxis influences on the coexistence of predator and prey. This dispersal of predators could give them a greater possibility to coexist in the ecosystem than random dispersal (Theorems 2.6, 2.8 and 2.9). Thus, we conclude that the dispersal considered in this work plays a vital role in the survival of the predator and the coexistence in the predator–prey system.

    This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2015R1A2A2A01007013; NRF-2018R1C1B5039938).

    All authors declare no conflicts of interest in this paper.

    [1] De Strooper B, Saftig P, Craessaerts K, et al. (1998) Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature 391: 387-390. doi: 10.1038/34910
    [2] Jankowsky JL, Fadale DJ, Anderson J, et al. (2004) Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum Mol Genet 13: 159-170. doi: 10.1093/hmg/ddh019
    [3] Clark RF, Hutton M, Fuldner M, et al. (1995) The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families. Nat Genet 11: 219-222. doi: 10.1038/ng1095-219
    [4] Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297: 353-356. doi: 10.1126/science.1072994
    [5] Weksler ME, Gouras G, Relkin NR, et al. (2005) The immune system, amyloid-beta peptide, and Alzheimer's disease. Immunol Rev 205: 244-256. doi: 10.1111/j.0105-2896.2005.00264.x
    [6] Hass MR, Sato C, Kopan R, et al. (2009) Presenilin: RIP and beyond. Semin Cell Dev Biol 20: 201-210. doi: 10.1016/j.semcdb.2008.11.014
    [7] de Calignon A, Fox LM, Pitstick R, et al. (2010) Caspase activation precedes and leads to tangles. Nature 464: 1201-1204. doi: 10.1038/nature08890
    [8] Sleegers K, Lambert JC, Bertram L, et al. (2010) The pursuit of susceptibility genes for Alzheimer's disease: progress and prospects. Trends Genet 26: 84-93. doi: 10.1016/j.tig.2009.12.004
    [9] Bertram L, Tanzi RE (2008) Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses. Nat Rev Neurosci 9: 768-778. doi: 10.1038/nrn2494
    [10] Selkoe DJ, Hardy J (2016) The amyloid hypothesis of Alzheimer's disease at 25 years. EMBO Mol Med2016: e201606210. doi: 10.15252/emmm.201606210
    [11] Jones L, Holmans PA, Hamshere ML, et al. (2010) Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease. PLoS One 5: e13950. doi: 10.1371/journal.pone.0013950
    [12] Porcellini E, Carbone I, Ianni M, et al. (2010) Alzheimer's disease gene signature says: beware of brain viral infections. Immun Ageing 7: 16. doi: 10.1186/1742-4933-7-16
    [13] Wozniak MA, Itzhaki RF, Shipley SJ, et al. (2007) Herpes simplex virus infection causes cellular beta-amyloid accumulation and secretase upregulation. Neurosci Lett 429: 95-100. doi: 10.1016/j.neulet.2007.09.077
    [14] Wozniak MA, Mee AP, Itzhaki RF (2009) Herpes simplex virus type 1 DNA is located within Alzheimer's disease amyloid plaques. J Pathol 217: 131-138. doi: 10.1002/path.2449
    [15] Santana S, Recuero M, Bullido MJ, et al. (2012) Herpes simplex virus type I induces the accumulation of intracellular beta-amyloid in autophagic compartments and the inhibition of the non-amyloidogenic pathway in human neuroblastoma cells. Neurobiol Aging 33: 430.e419-433. doi: 10.1016/j.neurobiolaging.2010.12.010
    [16] Seshadri S, Fitzpatrick AL, Ikram MA, et al. (2010) Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA 303: 1832-1840. doi: 10.1001/jama.2010.574
    [17] Carter CJ (2010) Alzheimer's Disease: A Pathogenetic Autoimmune Disorder Caused by Herpes Simplex in a Gene-Dependent Manner. Int J Alzheimers Dis 2010: 140539. doi: 10.4061/2010/140539
    [18] Tolia A, De Strooper B (2009) Structure and function of γ-secretase. Semin Cell Dev Biol 20: 211-218. doi: 10.1016/j.semcdb.2008.10.007
    [19] Edbauer D, Winkler E, Regula JT, et al. (2003) Reconstitution of gamma-secretase activity. Nat Cell Biol 5: 486-488. doi: 10.1038/ncb960
    [20] Kimberly WT, LaVoie MJ, Ostaszewski BL, et al. (2003) Gamma-secretase is a membrane protein complex comprised of presenilin, nicastrin, Aph-1, and Pen-2. Proc Natl Acad Sci U S A 100: 6382-6387. doi: 10.1073/pnas.1037392100
    [21] Takasugi N, Tomita T, Hayashi I, et al. (2003) The role of presenilin cofactors in the gamma-secretase complex. Nature 422: 438-441. doi: 10.1038/nature01506
    [22] Fraering PC, Ye W, Strub JM, et al. (2004) Purification and characterization of the human gamma-secretase complex. Biochemistry 43: 9774-9789. doi: 10.1021/bi0494976
    [23] Winkler E, Hobson S, Fukumori A, et al. (2009) Purification, pharmacological modulation, and biochemical characterization of interactors of endogenous human gamma-secretase. Biochemistry 48: 1183-1197. doi: 10.1021/bi801204g
    [24] Sato T, Diehl TS, Narayanan S, et al. (2007) Active gamma-secretase complexes contain only one of each component. J Biol Chem 282: 33985-33993. doi: 10.1074/jbc.M705248200
    [25] Hebert SS, Serneels L, Dejaegere T, et al. (2004) Coordinated and widespread expression of gamma-secretase in vivo: evidence for size and molecular heterogeneity. Neurobiol Dis 17: 260-272. doi: 10.1016/j.nbd.2004.08.002
    [26] Shirotani K, Edbauer D, Prokop S, et al. (2004) Identification of distinct gamma-secretase complexes with different APH-1 variants. J Biol Chem 279: 41340-41345. doi: 10.1074/jbc.M405768200
    [27] Beel AJ, Sanders CR (2008) Substrate specificity of gamma-secretase and other intramembrane proteases. Cell Mol Life Sci 65: 1311-1334. doi: 10.1007/s00018-008-7462-2
    [28] Coen K, Annaert W (2010) Presenilins: how much more than gamma-secretase?! Biochem Soc Trans 38: 1474-1478. doi: 10.1042/BST0381474
    [29] McCarthy JV, Twomey C, Wujek P (2009) Presenilin-dependent regulated intramembrane proteolysis and γ-secretase activity. Cell Mol Life Sci 66: 1534-1555. doi: 10.1007/s00018-009-8435-9
    [30] Wolfe MS (2009) Intramembrane-cleaving Proteases. J Biol Chem 284: 13969-13973. doi: 10.1074/jbc.R800039200
    [31] Brown MS, Ye J, Rawson RB, et al. (2000) Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans. Cell 100: 391-398. doi: 10.1016/S0092-8674(00)80675-3
    [32] McCarthy JV, Twomey C, Wujek P (2009) Presenilin-dependent regulated intramembrane proteolysis and gamma-secretase activity. Cell Mol Life Sci 66: 1534-1555. doi: 10.1007/s00018-009-8435-9
    [33] Chhibber-Goel J, Coleman-Vaughan C, Agrawal V, et al. (2016) gamma-Secretase Activity Is Required for Regulated Intramembrane Proteolysis of Tumor Necrosis Factor (TNF) Receptor 1 and TNF-mediated Pro-apoptotic Signalling. J Biol Chem 291: 5971-5985. doi: 10.1074/jbc.M115.679076
    [34] Elzinga BM, Twomey C, Powell JC, et al. (2009) Interleukin-1 receptor type 1 is a substrate for gamma-secretase-dependent regulated intramembrane proteolysis. J Biol Chem 284: 1394-1409.
    [35] Kuhn PH, Marjaux E, Imhof A, et al. (2007) Regulated intramembrane proteolysis of the interleukin-1 receptor II by alpha-, beta-, and gamma-secretase. J Biol Chem 282: 11982-11995. doi: 10.1074/jbc.M700356200
    [36] Chalaris A, Gewiese J, Paliga K, et al. (2010) ADAM17-mediated shedding of the IL6R induces cleavage of the membrane stub by gamma-secretase. Biochim Biophys Acta 1803: 234-245. doi: 10.1016/j.bbamcr.2009.12.001
    [37] Schulte A, Schulz B, Andrzejewski MG, et al. (2007) Sequential processing of the transmembrane chemokines CX3CL1 and CXCL16 by alpha- and gamma-secretases. Biochem Biophys Res Commun 358: 233-240. doi: 10.1016/j.bbrc.2007.04.100
    [38] Donoviel DB, Hadjantonakis AK, Ikeda M, et al. (1999) Mice lacking both presenilin genes exhibit early embryonic patterning defects. Genes Dev 13: 2801-2810. doi: 10.1101/gad.13.21.2801
    [39] Xia X, Qian S, Soriano S, et al. (2001) Loss of presenilin 1 is associated with enhanced beta-catenin signalling and skin tumorigenesis. Proc Natl Acad Sci U S A 98: 10863-10868. doi: 10.1073/pnas.191284198
    [40] Guo Q, Fu W, Sopher BL, et al. (1999) Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice. Nat Med 5: 101-106. doi: 10.1038/4789
    [41] Feng R, Rampon C, Tang YP, et al. (2001) Deficient neurogenesis in forebrain-specific presenilin-1 knockout mice is associated with reduced clearance of hippocampal memory traces. Neuron 32: 911-926. doi: 10.1016/S0896-6273(01)00523-2
    [42] Wang R, Dineley KT, Sweatt JD, et al. (2004) Presenilin 1 familial Alzheimer's disease mutation leads to defective associative learning and impaired adult neurogenesis. Neuroscience 126: 305-312. doi: 10.1016/j.neuroscience.2004.03.048
    [43] Herreman A, Hartmann D, Annaert W, et al. (1999) Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency. Proc Natl Acad Sci U S A 96: 11872-11877. doi: 10.1073/pnas.96.21.11872
    [44] Tournoy J, Bossuyt X, Snellinx A, et al. (2004) Partial loss of presenilins causes seborrheic keratosis and autoimmune disease in mice. Hum Mol Genet 13: 1321-1331. doi: 10.1093/hmg/ddh151
    [45] Maraver A, Tadokoro CE, Badura ML, et al. (2007) Effect of presenilins in the apoptosis of thymocytes and homeostasis of CD8+ T cells. Blood 110: 3218-3225. doi: 10.1182/blood-2007-01-070359
    [46] Laky K, Fowlkes BJ (2007) Presenilins regulate αβ T cell development by modulating TCR signalling. J Exp Med 204: 2115-2129. doi: 10.1084/jem.20070550
    [47] Yagi T, Giallourakis C, Mohanty S, et al. (2008) Defective signal transduction in B lymphocytes lacking presenilin proteins. Proc Natl Acad Sci U S A 105: 979-984. doi: 10.1073/pnas.0707755105
    [48] Beglopoulos V, Sun X, Saura CA, et al. (2004) Reduced beta-amyloid production and increased inflammatory responses in presenilin conditional knock-out mice. J Biol Chem 279: 46907-46914. doi: 10.1074/jbc.M409544200
    [49] Jayadev S, Case A, Eastman AJ, et al. (2010) Presenilin 2 Is the Predominant γ-Secretase in Microglia and Modulates Cytokine Release. PLoS ONE 5: e15743. doi: 10.1371/journal.pone.0015743
    [50] Glenn G, van der Geer P (2008) Toll-like receptors stimulate regulated intramembrane proteolysis of the CSF-1 receptor through Erk activation. FEBS Lett 582: 911-915. doi: 10.1016/j.febslet.2008.02.029
    [51] Garlind A, Brauner A, Hojeberg B, et al. (1999) Soluble interleukin-1 receptor type II levels are elevated in cerebrospinal fluid in Alzheimer's disease patients. Brain Res 826: 112-116. doi: 10.1016/S0006-8993(99)01092-6
    [52] Dinarello CA (2011) Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 117: 3720-3732. doi: 10.1182/blood-2010-07-273417
    [53] Twomey C, Qian S, McCarthy JV (2009) TRAF6 promotes ubiquitination and regulated intramembrane proteolysis of IL-1R1. Biochem Biophys Res Commun 381: 418-423. doi: 10.1016/j.bbrc.2009.02.051
    [54] Powell JC, Twomey C, Jain R, et al. (2009) Association between Presenilin-1 and TRAF6 modulates regulated intramembrane proteolysis of the p75NTR neurotrophin receptor. J Neurochem 108: 216-230. doi: 10.1111/j.1471-4159.2008.05763.x
    [55] Curtis BM, Widmer MB, deRoos P, et al. (1990) IL-1 and its receptor are translocated to the nucleus. J Immunol 144: 1295-1303.
    [56] Levine SJ (2008) Molecular Mechanisms of Soluble Cytokine Receptor Generation. J Biol Chem 283: 14177-14181. doi: 10.1074/jbc.R700052200
    [57] Frykman S, Hur JY, Franberg J, et al. (2010) Synaptic and endosomal localization of active gamma-secretase in rat brain. PLoS One 5: e8948. doi: 10.1371/journal.pone.0008948
    [58] Meckler X, Checler F (2016) Presenilin 1 and Presenilin 2 Target gamma-Secretase Complexes to Distinct Cellular Compartments. J Biol ChemM115: 708297.
    [59] Doody RS, Raman R, Farlow M, et al. (2013) A phase 3 trial of semagacestat for treatment of Alzheimer's disease. N Engl J Med 369: 341-350. doi: 10.1056/NEJMoa1210951
    [60] Goodbourn S, Didcock L, Randall RE (2000) Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J Gen Virol 81: 2341-2364. doi: 10.1099/0022-1317-81-10-2341
    [61] Saleh AZ, Fang AT, Arch AE, et al. (2004) Regulated proteolysis of the IFNaR2 subunit of the interferon-alpha receptor. Oncogene 23: 7076-7086. doi: 10.1038/sj.onc.1207955
    [62] Garton KJ, Gough PJ, Raines EW (2006) Emerging roles for ectodomain shedding in the regulation of inflammatory responses. J Leukoc Biol 79: 1105-1116. doi: 10.1189/jlb.0106038
    [63] Mambole A, Baruch D, Nusbaum P, et al. (2008) The cleavage of neutrophil leukosialin (CD43) by cathepsin G releases its extracellular domain and triggers its intramembrane proteolysis by presenilin/gamma-secretase. J Biol Chem 283: 23627-23635. doi: 10.1074/jbc.M710286200
    [64] Cui W, Ke JZ, Zhang Q, et al. (2006) The intracellular domain of CD44 promotes the fusion of macrophages. Blood 107: 796-805. doi: 10.1182/blood-2005-05-1902
    [65] Carey BW, Kim DY, Kovacs DM (2007) Presenilin/gamma-secretase and alpha-secretase-like peptidases cleave human MHC Class I proteins. Biochem J 401: 121-127. doi: 10.1042/BJ20060847
    [66] Bonifati DM, Kishore U (2007) Role of complement in neurodegeneration and neuroinflammation. Mol Immunol 44: 999-1010. doi: 10.1016/j.molimm.2006.03.007
    [67] Veerhuis R, Nielsen HM, Tenner AJ (2011) Complement in the brain. Mol Immunol 48: 1592-1603. doi: 10.1016/j.molimm.2011.04.003
    [68] Fonseca MI, Chu SH, Berci AM, et al. (2011) Contribution of complement activation pathways to neuropathology differs among mouse models of Alzheimer's disease. J Neuroinflammation 8: 4. doi: 10.1186/1742-2094-8-4
    [69] Webster SD, Galvan MD, Ferran E, et al. (2001) Antibody-Mediated Phagocytosis of the Amyloid β-Peptide in Microglia Is Differentially Modulated by C1q. J Immunol 166: 7496-7503. doi: 10.4049/jimmunol.166.12.7496
    [70] Fonseca MI, Zhou J, Botto M, et al. (2004) Absence of C1q leads to less neuropathology in transgenic mouse models of Alzheimer's disease. J Neurosci 24: 6457-6465. doi: 10.1523/JNEUROSCI.0901-04.2004
    [71] Fraser DA, Pisalyaput K, Tenner AJ (2010) C1q enhances microglial clearance of apoptotic neurons and neuronal blebs, and modulates subsequent inflammatory cytokine production. J Neurochem 112: 733-743. doi: 10.1111/j.1471-4159.2009.06494.x
    [72] Rogers J, Li R, Mastroeni D, et al. (2006) Peripheral clearance of amyloid beta peptide by complement C3-dependent adherence to erythrocytes. Neurobiol Aging 27: 1733-1739. doi: 10.1016/j.neurobiolaging.2005.09.043
    [73] Akiyama H, Barger S, Barnum S, et al. (2000) Inflammation and Alzheimer's disease. Neurobiol Aging 21: 383-421. doi: 10.1016/S0197-4580(00)00124-X
    [74] Spitzer P, Herrmann M, Klafki H-W, et al. (2010) Phagocytosis and LPS alter the maturation state of β-amyloid precursor protein and induce different Aβ peptide release signatures in human mononuclear phagocytes. J Neuroinflammation 7: 59-59. doi: 10.1186/1742-2094-7-59
    [75] Morgan D, Gordon MN, Tan J, et al. (2005) Dynamic complexity of the microglial activation response in transgenic models of amyloid deposition: implications for Alzheimer therapeutics. J Neuropathol Exp Neurol 64: 743-753. doi: 10.1097/01.jnen.0000178444.33972.e0
    [76] Streit WJ (2004) Microglia and Alzheimer's disease pathogenesis. J Neurosci Res 77: 1-8. doi: 10.1002/jnr.20093
    [77] Trudler D, Farfara D, Frenkel D (2010) Toll-Like Receptors Expression and Signalling in Glia Cells in Neuro-Amyloidogenic Diseases: Towards Future Therapeutic Application. Mediators of Inflammation 2010: 12.
    [78] Kumar H, Kawai T, Akira S (2011) Pathogen recognition by the innate immune system. Int Rev Immunol 30: 16-34. doi: 10.3109/08830185.2010.529976
    [79] Carty M, Bowie AG (2011) Evaluating the role of Toll-like receptors in diseases of the central nervous system. Biochem Pharmacol 81: 825-837. doi: 10.1016/j.bcp.2011.01.003
    [80] Chen F, Hasegawa H, Schmitt-Ulms G, et al. (2006) TMP21 is a presenilin complex component that modulates [gamma]-secretase but not [epsiv]-secretase activity. Nature 440: 1208-1212. doi: 10.1038/nature04667
    [81] Iribarren P, Chen K, Hu J, et al. (2005) CpG-containing oligodeoxynucleotide promotes microglial cell uptake of amyloid beta 1-42 peptide by up-regulating the expression of the G-protein- coupled receptor mFPR2. FASEBJ 19: 2032-2034.
    [82] Jin JJ, Kim HD, Maxwell JA, et al. (2008) Toll-like receptor 4-dependent upregulation of cytokines in a transgenic mouse model of Alzheimer's disease. J Neuroinflammation 5: 23. doi: 10.1186/1742-2094-5-23
    [83] Herber DL, Mercer M, Roth LM, et al. (2007) Microglial activation is required for Abeta clearance after intracranial injection of lipopolysaccharide in APP transgenic mice. J Neuroimmune Pharmacol 2: 222-231. doi: 10.1007/s11481-007-9069-z
    [84] DiCarlo G, Wilcock D, Henderson D, et al. (2001) Intrahippocampal LPS injections reduce Abeta load in APP+PS1 transgenic mice. Neurobiol Aging 22: 1007-1012. doi: 10.1016/S0197-4580(01)00292-5
    [85] Richard KL, Filali M, Prefontaine P, et al. (2008) Toll-like receptor 2 acts as a natural innate immune receptor to clear amyloid beta 1-42 and delay the cognitive decline in a mouse model of Alzheimer's disease. J Neurosci 28: 5784-5793. doi: 10.1523/JNEUROSCI.1146-08.2008
    [86] Jana M, Palencia CA, Pahan K (2008) Fibrillar amyloid-beta peptides activate microglia via TLR2: implications for Alzheimer's disease. J Immunol 181: 7254-7262. doi: 10.4049/jimmunol.181.10.7254
    [87] Frank S, Copanaki E, Burbach GJ, et al. (2009) Differential regulation of toll-like receptor mRNAs in amyloid plaque-associated brain tissue of aged APP23 transgenic mice. Neurosci Lett 453: 41-44. doi: 10.1016/j.neulet.2009.01.075
    [88] Michaud J-P, Richard KL, Rivest S (2011) MyD88-adaptor protein acts as a preventive mechanism for memory deficits in a mouse model of Alzheimer's disease. Mol Neurodegener 6: 5-5. doi: 10.1186/1750-1326-6-5
    [89] Cui JG, Li YY, Zhao Y, et al. (2010) Differential regulation of interleukin-1 receptor-associated kinase-1 (IRAK-1) and IRAK-2 by microRNA-146a and NF-kappaB in stressed human astroglial cells and in Alzheimer disease. J Biol Chem 285: 38951-38960. doi: 10.1074/jbc.M110.178848
    [90] Standridge JB (2006) Vicious cycles within the neuropathophysiologic mechanisms of Alzheimer's disease. Curr Alzheimer Res 3: 95-108. doi: 10.2174/156720506776383068
    [91] Lue LF, Walker DG, Rogers J (2001) Modeling microglial activation in Alzheimer's disease with human postmortem microglial cultures. Neurobiol Aging 22: 945-956. doi: 10.1016/S0197-4580(01)00311-6
    [92] Yan Q, Zhang J, Liu H, et al. (2003) Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease. J Neurosci 23: 7504-7509.
    [93] Yamamoto M, Kiyota T, Horiba M, et al. (2007) Interferon-γ and Tumor Necrosis Factor-α Regulate Amyloid-β Plaque Deposition and β-Secretase Expression in Swedish Mutant APP Transgenic Mice. Am J Pathol 170: 680-692. doi: 10.2353/ajpath.2007.060378
    [94] Kong Q, Peterson TS, Baker O, et al. (2009) Interleukin-1beta enhances nucleotide-induced and alpha-secretase-dependent amyloid precursor protein processing in rat primary cortical neurons via up-regulation of the P2Y(2) receptor. J Neurochem 109: 1300-1310. doi: 10.1111/j.1471-4159.2009.06048.x
    [95] Sheng JG, Zhu SG, Jones RA, et al. (2000) Interleukin-1 Promotes Expression and Phosphorylation of Neurofilament and tau Proteins in Vivo. Exp Neurol 163: 388-391. doi: 10.1006/exnr.2000.7393
    [96] Moses GS, Jensen MD, Lue LF, et al. (2006) Secretory PLA2-IIA: a new inflammatory factor for Alzheimer's disease. J Neuroinflammation 3: 28. doi: 10.1186/1742-2094-3-28
    [97] Rezai-Zadeh K, Gate D, Gowing G, et al. (2011) How to Get from Here to There: Macrophage Recruitment in Alzheimer's Disease. Curr Alzheimer Res 8: 156-163. doi: 10.2174/156720511795256017
    [98] Shaftel SS, Kyrkanides S, Olschowka JA, et al. (2007) Sustained hippocampal IL-1 beta overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology. J Clin Invest 117: 1595-1604. doi: 10.1172/JCI31450
    [99] Rogers J, Strohmeyer R, Kovelowski CJ, et al. (2002) Microglia and inflammatory mechanisms in the clearance of amyloid beta peptide. Glia 40: 260-269. doi: 10.1002/glia.10153
    [100] Jutras I, Laplante A, Boulais J, et al. (2005) Gamma-secretase is a functional component of phagosomes. J Biol Chem 280: 36310-36317. doi: 10.1074/jbc.M504069200
    [101] Kiyota T, Yamamoto M, Xiong H, et al. (2009) CCL2 Accelerates Microglia-Mediated Aβ Oligomer Formation and Progression of Neurocognitive Dysfunction. PLoS ONE 4: e6197. doi: 10.1371/journal.pone.0006197
    [102] El Khoury J, Toft M, Hickman SE, et al. (2007) Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat Med 13: 432-438. doi: 10.1038/nm1555
    [103] De Strooper B, Chavez Gutierrez L (2015) Learning by failing: ideas and concepts to tackle gamma-secretases in Alzheimer's disease and beyond. Annu Rev Pharmacol Toxicol 55: 419-437. doi: 10.1146/annurev-pharmtox-010814-124309
    [104] Beher D, Clarke EE, Wrigley JD, et al. (2004) Selected non-steroidal anti-inflammatory drugs and their derivatives target gamma-secretase at a novel site. Evidence for an allosteric mechanism. J Biol Chem 279: 43419-43426.
    [105] Kukar T, Golde TE (2008) Possible mechanisms of action of NSAIDs and related compounds that modulate gamma-secretase cleavage. Curr Top Med Chem 8: 47-53. doi: 10.2174/156802608783334042
    [106] Wong GT, Manfra D, Poulet FM, et al. (2004) Chronic treatment with the gamma-secretase inhibitor LY-411,575 inhibits beta-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation. J Biol Chem 279: 12876-12882. doi: 10.1074/jbc.M311652200
    [107] Jack C, Berezovska O, Wolfe MS, et al. (2001) Effect of PS1 deficiency and an APP gamma-secretase inhibitor on Notch1 signalling in primary mammalian neurons. Brain Res Mol Brain Res 87: 166-174. doi: 10.1016/S0169-328X(01)00010-9
    [108] Geling A, Steiner H, Willem M, et al. (2002) A gamma-secretase inhibitor blocks Notch signalling in vivo and causes a severe neurogenic phenotype in zebrafish. EMBO Rep 3: 688-694. doi: 10.1093/embo-reports/kvf124
    [109] Micchelli CA, Esler WP, Kimberly WT, et al. (2003) Gamma-secretase/presenilin inhibitors for Alzheimer's disease phenocopy Notch mutations in Drosophila. FASEB J 17: 79-81.
    [110] Henley DB, Sundell KL, Sethuraman G, et al. (2014) Safety profile of semagacestat, a gamma-secretase inhibitor: IDENTITY trial findings. Curr Med Res Opin 30: 2021-2032. doi: 10.1185/03007995.2014.939167
    [111] Panza F, Frisardi V, Imbimbo BP, et al. (2010) REVIEW: gamma-Secretase inhibitors for the treatment of Alzheimer's disease: The current state. CNS Neurosci Ther 16: 272-284. doi: 10.1111/j.1755-5949.2010.00164.x
    [112] Frisardi V, Solfrizzi V, Imbimbo PB, et al. (2010) Towards disease-modifying treatment of Alzheimer's disease: drugs targeting beta-amyloid. Curr Alzheimer Res 7: 40-55. doi: 10.2174/156720510790274400
    [113] Bergmans BA, De Strooper B (2010) gamma-secretases: from cell biology to therapeutic strategies. Lancet Neurol 9: 215-226. doi: 10.1016/S1474-4422(09)70332-1
    [114] Samson K (2010) NerveCenter: Phase III Alzheimer trial halted: Search for therapeutic biomarkers continues. Ann Neurol 68: A9-a12.
    [115] Gillman KW, Starrett JE, Jr., Parker MF, et al. (2010) Discovery and Evaluation of BMS-708163, a Potent, Selective and Orally Bioavailable gamma-Secretase Inhibitor. ACS Med Chem Lett 1: 120-124. doi: 10.1021/ml1000239
    [116] De Strooper B (2014) Lessons from a failed gamma-secretase Alzheimer trial. Cell 159: 721-726. doi: 10.1016/j.cell.2014.10.016
    [117] Cummings J (2010) What Can Be Inferred from the Interruption of the Semagacestat Trial for Treatment of Alzheimer's Disease? Biol Psychiatry 68: 876-878. doi: 10.1016/j.biopsych.2010.09.020
    [118] Qyang Y, Chambers SM, Wang P, et al. (2004) Myeloproliferative disease in mice with reduced presenilin gene dosage: effect of gamma-secretase blockage. Biochemistry 43: 5352-5359. doi: 10.1021/bi049826u
    [119] Imbimbo BP (2008) Therapeutic potential of gamma-secretase inhibitors and modulators. Curr Top Med Chem 8: 54-61. doi: 10.2174/156802608783334015
    [120] Pul R, Dodel R, Stangel M (2011) Antibody-based therapy in Alzheimer's disease. Expert Opin Biol Ther 11: 343-357. doi: 10.1517/14712598.2011.552884
    [121] Sarazin M, Dorothee G, de Souza LC, et al. (2013) Immunotherapy in Alzheimer's disease: do we have all the pieces of the puzzle? Biol Psychiatry 74: 329-332. doi: 10.1016/j.biopsych.2013.04.011
    [122] Brodaty H, Breteler MM, Dekosky ST, et al. (2011) The world of dementia beyond 2020. J Am Geriatr Soc 59: 923-927. doi: 10.1111/j.1532-5415.2011.03365.x
    [123] Yamada K, Yabuki C, Seubert P, et al. (2009) Abeta immunotherapy: intracerebral sequestration of Abeta by an anti-Abeta monoclonal antibody 266 with high affinity to soluble Abeta. J Neurosci 29: 11393-11398. doi: 10.1523/JNEUROSCI.2021-09.2009
    [124] Schenk D, Barbour R, Dunn W, et al. (1999) Immunization with amyloid-[beta] attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400: 173-177. doi: 10.1038/22124
    [125] Lemere CA, Spooner ET, Leverone JF, et al. (2003) Amyloid-beta immunization in Alzheimer's disease transgenic mouse models and wildtype mice. Neurochem Res 28: 1017-1027. doi: 10.1023/A:1023203122036
    [126] Fu HJ, Liu B, Frost JL, et al. (2010) Amyloid-beta immunotherapy for Alzheimer's disease. CNS Neurol Disord Drug Targets 9: 197-206. doi: 10.2174/187152710791012017
    [127] Robert R, Dolezal O, Waddington L, et al. (2009) Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers. Protein Eng Des Sel 22: 199-208.
    [128] Marin-Argany M, Rivera-Hernandez G, Marti J, et al. (2011) An anti-Abeta (amyloid beta) single-chain variable fragment prevents amyloid fibril formation and cytotoxicity by withdrawing Abeta oligomers from the amyloid pathway. Biochem J 437: 25-34. doi: 10.1042/BJ20101712
    [129] Panza F, Frisardi V, Imbimbo BP, et al. (2011) Anti-beta-amyloid immunotherapy for Alzheimer's disease: focus on bapineuzumab. Curr Alzheimer Res 8: 808-817. doi: 10.2174/156720511798192718
    [130] Lambracht-Washington D, Qu BX, Fu M, et al. (2011) DNA immunization against amyloid beta 42 has high potential as safe therapy for Alzheimer's disease as it diminishes antigen-specific Th1 and Th17 cell proliferation. Cell Mol Neurobiol 31: 867-874. doi: 10.1007/s10571-011-9680-7
    [131] Salloway S, Sperling R, Brashear HR (2014) Phase 3 trials of solanezumab and bapineuzumab for Alzheimer's disease. N Engl J Med 370: 1460. doi: 10.1056/NEJMc1402193
    [132] Salloway S, Sperling R, Fox NC, et al. (2014) Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease. N Engl J Med 370: 322-333. doi: 10.1056/NEJMoa1304839
    [133] Krishnamurthy PK, Sigurdsson EM (2011) Therapeutic applications of antibodies in non-infectious neurodegenerative diseases. New Biotechnol 28: 511-517. doi: 10.1016/j.nbt.2011.03.020
    [134] Britschgi M, Wyss-Coray T (2009) Blood protein signature for the early diagnosis of Alzheimer disease. Arch Neurol 66: 161-165. doi: 10.1001/archneurol.2008.530
    [135] Lindberg C, Chromek M, Ahrengart L, et al. (2005) Soluble interleukin-1 receptor type II, IL-18 and caspase-1 in mild cognitive impairment and severe Alzheimer's disease. Neurochem Int 46: 551-557. doi: 10.1016/j.neuint.2005.01.004
    [136] Reddy MM, Wilson R, Wilson J, et al. (2011) Identification of Candidate IgG Biomarkers for Alzheimer's Disease via Combinatorial Library Screening. Cell 144: 132-142. doi: 10.1016/j.cell.2010.11.054
  • This article has been cited by:

    1. Rina Su, Chunrui Zhang, The generation mechanism of Turing-pattern in a Tree-grass competition model with cross diffusion and time delay, 2022, 19, 1551-0018, 12073, 10.3934/mbe.2022562
    2. Wonhyung Choi, Kwangjoong Kim, Inkyung Ahn, Predation-induced dispersal toward fitness for predator invasion in predator–prey models, 2023, 17, 1751-3758, 10.1080/17513758.2023.2166133
    3. Toan D. Ha, Vyacheslav G. Tsybulin, Pavel A. Zelenchuk, How to model the local interaction in the predator–prey system at slow diffusion in a heterogeneous environment?, 2022, 52, 1476945X, 101026, 10.1016/j.ecocom.2022.101026
    4. T. D. Ha, V. G. Tsybulin, Multistability for a Mathematical Model of the Dynamics of Predators and Preys in a Heterogeneous Area, 2022, 68, 2413-3639, 509, 10.22363/2413-3639-2022-68-3-509-521
    5. Wonhyung Choi, Kwangjoong Kim, Inkyung Ahn, Predator-prey models with prey-dependent diffusion on predators in spatially heterogeneous habitat, 2023, 525, 0022247X, 127130, 10.1016/j.jmaa.2023.127130
    6. T. D. Ha, V. G. Tsybulin, Multistability for a Mathematical Model of the Dynamics of Predators and Prey in a Heterogeneous Area, 2024, 282, 1072-3374, 417, 10.1007/s10958-024-07185-y
    7. P. A. Zelenchuk, V. G. Tsybulin, Mathematical model of ideal free distribution in the predator-prey system, 2023, 69, 2949-0618, 237, 10.22363/2413-3639-2023-69-2-237-249
    8. P. A. Zelenchuk, V. G. Tsybulin, Mathematical Model of Ideal Free Distribution in the Predator–Prey System, 2024, 1072-3374, 10.1007/s10958-024-07445-x
  • Reader Comments
  • © 2016 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(7058) PDF downloads(1263) Cited by(2)

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog